Free Trial

Madrigal Pharmaceuticals (MDGL) SEC Filings & 10K Form

Madrigal Pharmaceuticals logo
$359.00 +9.50 (+2.72%)
Closing price 04:00 PM Eastern
Extended Trading
$358.54 -0.46 (-0.13%)
As of 07:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Madrigal Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/11/2025
3:26 PM
Madrigal Pharmaceuticals (Subject)
Taub Rebecca (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/11/2025
3:26 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2025
6:17 PM
Brennan Daniel J. (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/05/2025
6:23 PM
Brennan Daniel J. (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
7:59 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2025
6:05 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2025
5:30 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2025
4:06 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2025
4:08 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2025
7:29 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2025
4:25 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/18/2025
4:03 PM
Madrigal Pharmaceuticals (Subject)
Taub Rebecca (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2025
3:20 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2025
3:21 PM
Madrigal Pharmaceuticals (Subject)
Taub Rebecca (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2025
3:19 PM
Madrigal Pharmaceuticals (Subject)
Taub Rebecca (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2025
3:20 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2025
3:45 PM
BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:30 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:34 PM
Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:38 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:39 PM
FOUSE JACQUALYN A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
3:22 PM
Madrigal Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/16/2025
5:23 PM
Madrigal Pharmaceuticals (Issuer)
Soergel David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
11:15 AM
JANUS HENDERSON GROUP PLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
05/01/2025
7:53 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2025
6:02 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
3:16 PM
Madrigal Pharmaceuticals (Filer)
Form DEF 14A
04/24/2025
4:03 PM
Madrigal Pharmaceuticals (Issuer)
Soergel David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
3:52 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2025
3:25 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
4:03 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
12:26 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144/A
03/12/2025
3:24 PM
FOUSE JACQUALYN A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2025
3:29 PM
FOUSE JACQUALYN A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:32 PM
Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:11 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2025
7:05 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
4:43 PM
Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
4:47 PM
Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
4:40 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
4:00 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This New Rule Could Change Everything (Ad)

A new rule taking effect this September has Big Banks shifting billions into one asset they now treat like cash. Not stocks. Not bonds. Not even the dollar. If your retirement savings are still tied up in traditional accounts, you could be on the wrong side of this move. But there’s still time to reposition before the dollar takes another hit.

Click here to get your FREE Gold Retirement Guide and see how to protect your savings tax- and penal
03/07/2025
3:50 PM
Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:31 PM
Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:31 PM
Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:07 PM
Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
8:24 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:27 PM
Dier Mardi (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
3:59 PM
Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
3:31 PM
Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:36 PM
Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:51 PM
BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
3:54 PM
Daly James M (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
8:09 AM
Madrigal Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2025
6:05 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
11:10 AM
JANUS HENDERSON GROUP PLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/27/2025
4:12 PM
Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
4:18 PM
Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
4:07 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
4:03 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
5:00 PM
Madrigal Pharmaceuticals (Subject)
Sibold William John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
5:00 PM
Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
5:00 PM
Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
5:00 PM
Madrigal Pharmaceuticals (Subject)
Taub Rebecca (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
6:05 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:08 PM
Madrigal Pharmaceuticals (Issuer)
Waltermire Robert E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:10 PM
Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
4:30 PM
Madrigal Pharmaceuticals (Subject)
Waltermire Robert E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
4:30 PM
Madrigal Pharmaceuticals (Subject)
Taub Rebecca (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
4:30 PM
Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
5:50 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
3:46 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:16 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:10 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
3:30 PM
Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:30 PM
Huntsman Carole (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:18 PM
Madrigal Pharmaceuticals (Subject)
PAULSON & CO. INC. (Filed by)
Form SC 13G/A
11/14/2024
5:30 AM
Madrigal Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
11/08/2024
4:07 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
6:01 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:47 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
3:32 PM
Madrigal Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/31/2024
8:02 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
6:05 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
7:36 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
8:51 PM
Madrigal Pharmaceuticals (Issuer)
Sibold William John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
8:29 PM
Madrigal Pharmaceuticals (Subject)
Sibold William John (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
7:16 PM
Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
6:52 PM
Kelley Shannon T (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MDGL) was last updated on 8/12/2025 by MarketBeat.com Staff
From Our Partners